Dr. Erik Yeo
Claim this profileToronto General Hospital
Studies Blood Clot
Studies Deep Vein Thrombosis
5 reported clinical trials
7 drugs studied
Affiliated Hospitals
Clinical Trials Erik Yeo is currently running
Rivaroxaban vs Apixaban
for Blood Clots
Apixaban and rivaroxaban have been compared to standard therapy for treatment of acute symptomatic venous thromboembolism (VTE) in randomized controlled trials (RCTs), and are both approved by Health Canada. No safety or efficacy data is available from direct head-to-head comparison of these two anticoagulants. Lawsuits in the United States over bleeding events, patient perceptions, and concerns with medication adherence are additional factors highlighting the importance of a comparison trial. This multi-center, pragmatic, prospective, randomized, open-label, blinded end-point (PROBE) trial aims to compare the safety of apixaban and rivaroxaban for the treatment of VTE.
Recruiting3 awards Phase 43 criteria
Statins
for Blood Clots
The standard or usual treatment for patients diagnosed with deep vein thrombosis or pulmonary embolism is treatment with blood thinners (called anticoagulants). While treatment of blood clots with blood thinners is effective, some research has shown that adding a statin (medication used to lower cholesterol) may give extra protection. It is thought that statins can improve how cells along the walls of the vein control inflammation, which can prevent new blood clots from forming. The medication in this study, rosuvastatin, is approved in Canada for use as a cholesterol-lowering medication. The use of rosuvastatin in this study is considered investigational. This means that Health Canada has not approved the use of rosuvastatin as a treatment for blood clots. However, it has been approved for use in this research study. The purpose of this study is to examine if adding a statin (rosuvastatin) to the usual blood thinner treatment will decrease the risk of another blood clot forming. The investigators also hope to discover if taking a statin reduces damage to your veins. To do this, some of the participants in this study will get rosuvastatin and others will receive a placebo (a substance that looks like the study rosuvastatin but does not have any active or medicinal ingredients). The placebo in this study is not intended to have any effect on your blood clot. A placebo is used to make the results of the study more reliable.
Recruiting1 award Phase 31 criteria
More about Erik Yeo
Clinical Trial Related6 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Erik Yeo has experience with
- Apixaban
- Abelacimab
- Rivaroxaban
- Limited Cancer Screening
- Limited Cancer Screening + FDG PET/CT
- Rosuvastatin Calcium
Breakdown of trials Erik Yeo has run
Blood Clot
Deep Vein Thrombosis
Pulmonary Embolism
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Erik Yeo specialize in?
Erik Yeo focuses on Blood Clot and Deep Vein Thrombosis. In particular, much of their work with Blood Clot has involved treating patients, or patients who are undergoing treatment.
Is Erik Yeo currently recruiting for clinical trials?
Yes, Erik Yeo is currently recruiting for 4 clinical trials in Toronto Ontario. If you're interested in participating, you should apply.
Are there any treatments that Erik Yeo has studied deeply?
Yes, Erik Yeo has studied treatments such as Apixaban, Abelacimab, Rivaroxaban.
What is the best way to schedule an appointment with Erik Yeo?
Apply for one of the trials that Erik Yeo is conducting.
What is the office address of Erik Yeo?
The office of Erik Yeo is located at: Toronto General Hospital, Toronto, Ontario M5G 2C4 Canada. This is the address for their practice at the Toronto General Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.